BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Horng HC, Wen KC, Wang PH, Chen YJ, Yen MS, Ng HT; Taiwan Association of Gynecology Systematic Review Group. Uterine sarcoma Part II-Uterine endometrial stromal sarcoma: The TAG systematic review. Taiwan J Obstet Gynecol. 2016;55:472-479. [PMID: 27590366 DOI: 10.1016/j.tjog.2016.04.034] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Guijarro-Campillo AR, Segarra Vidal B, Lago V, Padilla-Iserte P, Hernández Chinchilla JA, Martín-González I, Domingo Del Pozo S. Low-grade endometrial stromal sarcoma with intravenous thrombus extension: a multidisciplinary surgical challenge. J Gynecol Oncol 2023;34:e21. [PMID: 36562130 DOI: 10.3802/jgo.2023.34.e21] [Reference Citation Analysis]
2 R Gregg A. A rare case of high-grade endometrial stromal sarcoma initially misdiagnosed as a uterine fibroid in a postmenopausal woman. Int J Case Rep Images 2022;13:122-127. [DOI: 10.5348/101341z01ag2022cr] [Reference Citation Analysis]
3 Hao Z, Yang S. The role of postoperative radiotherapy in patients with uterine sarcomas: A PSM-IPTW analysis based on SEER database. Front Surg 2022;9. [DOI: 10.3389/fsurg.2022.985654] [Reference Citation Analysis]
4 Chen J, Wang J, Cao D, Yang J, Huang H, Pan L, Xiang Y. Low-grade endometrial stromal sarcoma with intracaval or intracardiac extension: a retrospective study of eight cases. Arch Gynecol Obstet. [DOI: 10.1007/s00404-021-06373-4] [Reference Citation Analysis]
5 Niu S, Zheng W. Endometrial stromal tumors: Diagnostic updates and challenges. Seminars in Diagnostic Pathology 2022. [DOI: 10.1053/j.semdp.2022.01.004] [Reference Citation Analysis]
6 Kostov S, Kornovski Y, Ivanova V, Dzhenkov D, Metodiev D, Watrowski R, Ivanova Y, Slavchev S, Mitev D, Yordanov A. New Aspects of Sarcomas of Uterine Corpus-A Brief Narrative Review. Clin Pract 2021;11:878-900. [PMID: 34842646 DOI: 10.3390/clinpract11040103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Silva MG, Banazol N, Coelho P, Fragata JIG. Metastatic endometrial stromal sarcoma: A rare cause of right-sided intracardiac mass. J Card Surg 2021;36:2143-5. [PMID: 33651415 DOI: 10.1111/jocs.15463] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Fan JK, Tang GC, Yang H. Endometrial stromal sarcoma extending to the pulmonary artery: A rare case report. World J Clin Cases 2020; 8(22): 5625-5631 [PMID: 33344553 DOI: 10.12998/wjcc.v8.i22.5625] [Reference Citation Analysis]
9 Cabrera S, Bebia V, Acosta U, Franco-Camps S, Mañalich L, García-Jiménez A, Gil-Moreno A. Survival outcomes and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma. Clin Transl Oncol 2021;23:1210-9. [PMID: 33210235 DOI: 10.1007/s12094-020-02512-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
10 Gorostiaga I, Perez-Rodriguez A, Gómez-Mateo MC, Cuadra-Cestafe M, Sagasta A. Low-grade extrauterine endometrial stromal sarcoma of the peritoneum: A case report and literature review. Rev Esp Patol 2021;54:201-5. [PMID: 34175034 DOI: 10.1016/j.patol.2020.06.009] [Reference Citation Analysis]
11 Capozzi VA, Monfardini L, Ceni V, Cianciolo A, Butera D, Gaiano M, Berretta R. Endometrial stromal sarcoma: A review of rare mesenchymal uterine neoplasm. J Obstet Gynaecol Res 2020;46:2221-36. [PMID: 32830415 DOI: 10.1111/jog.14436] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
12 Patel SB, McCormack C, Hodge JC. Non-fusion mutations in endometrial stromal sarcomas: what is the potential impact on tumourigenesis through cell cycle dysregulation? J Clin Pathol 2020;73:830-5. [PMID: 32385140 DOI: 10.1136/jclinpath-2020-206432] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Han L, Liu YJ, Ricciotti RW, Mantilla JG. A novel MBTD1-PHF1 gene fusion in endometrial stromal sarcoma: A case report and literature review. Genes Chromosomes Cancer 2020;59:428-32. [PMID: 32237188 DOI: 10.1002/gcc.22845] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
14 Purbadi S, Saspriyana KY. Recurrent endometrial stromal sarcoma in the abdominal wall following a total hysterectomy: A rare case report. Int J Surg Case Rep 2020;68:242-5. [PMID: 32197223 DOI: 10.1016/j.ijscr.2020.03.003] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Tadic M, Belyavskiy E, Cuspidi C, Pieske B, Haßfeld S. Right heart masses in a patient with endometrial stromal sarcoma. J Clin Ultrasound 2020;48:117-20. [PMID: 31074021 DOI: 10.1002/jcu.22732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Batra Modi K. Uterine Sarcomas: Review and Update. Recent Advances in Endometrial Cancer 2020. [DOI: 10.1007/978-981-15-5317-2_16] [Reference Citation Analysis]
17 Doval D, Pasricha S. Endometrial stromal sarcoma: A rare tumor with therapeutic conundrums. Cancer Res Stat Treat 2020;3:583. [DOI: 10.4103/crst.crst_228_20] [Reference Citation Analysis]
18 Lee WL, Chan IS, Wang PH. Uterine sarcoma: An unusual but high lethal disease of gynecological malignancies. J Chin Med Assoc 2020;83:213-4. [PMID: 31868858 DOI: 10.1097/JCMA.0000000000000242] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Grindstaff SL, DiSilvestro J, Hansen K, DiSilvestro P, Sung CJ, Quddus MR. COL1A1-PDGFB fusion uterine fibrosarcoma: A case report with treatment implication. Gynecol Oncol Rep 2020;31:100523. [PMID: 31921959 DOI: 10.1016/j.gore.2019.100523] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
20 Comert GK, Turkmen O, Kar I, Yucel O, Kilic C, Boran N, Basaran D, Karalok A, Turan T. Hormone therapy following surgery in low-grade endometrial stromal sarcoma: Is it related to a decrease in recurrence rate? J Chin Med Assoc 2019;82:385-9. [PMID: 31058712 DOI: 10.1097/JCMA.0000000000000039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
21 Comert GK, Karalok A, Turan T. Reply to "The routine use of progestins might be a good choice for patients with recurrent low-grade endometrial stromal sarcoma after definite surgery". J Chin Med Assoc 2019;82:525. [PMID: 31008813 DOI: 10.1097/JCMA.0000000000000108] [Reference Citation Analysis]
22 Lee WL, Lee FK, Wang PH. Hormone therapy and low-grade endometrial stromal sarcoma. J Chin Med Assoc 2019;82:445-6. [PMID: 30932941 DOI: 10.1097/JCMA.0000000000000104] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
23 Li YT, Wang PH. The routine use of progestins might be a good choice for patients with recurrent low-grade endometrial stromal sarcoma after definite surgery. J Chin Med Assoc 2019;82:524. [PMID: 30932937 DOI: 10.1097/JCMA.0000000000000105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Patel SM, Tiwari R, Arora RS, Poddar P, Desai A, Mankad MH. Uterine Sarcomas: Surgical Management, Adjuvant Therapy and Survival Outcome. Experience at Gujarat Cancer and Research Institute. Indian J Gynecol Oncolog 2019;17:13. [DOI: 10.1007/s40944-018-0247-0] [Reference Citation Analysis]
25 Zhang YY, Li Y, Qin M, Cai Y, Jin Y, Pan LY. High-grade endometrial stromal sarcoma: a retrospective study of factors influencing prognosis. Cancer Manag Res. 2019;11:831-837. [PMID: 30697075 DOI: 10.2147/cmar.s187849] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
26 Shekhar S, Sharma C, Elhence P, Bansal S, Garg N. A Case of High-grade Endometrial Stromal Sarcoma: A Poignant Allegory. J Midlife Health 2019;10:209-12. [PMID: 31942159 DOI: 10.4103/jmh.JMH_8_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Ferreira J, Félix A, Lennerz JK, Oliva E. Recent advances in the histological and molecular classification of endometrial stromal neoplasms. Virchows Arch 2018;473:665-78. [DOI: 10.1007/s00428-018-2470-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
28 Zappacosta R, Fanfani F, Zappacosta B, Sablone F, Pansa L, Liberati M, Rosini S. Uterine Sarcomas: An Updated Overview. Neoplasm 2018. [DOI: 10.5772/intechopen.78980] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Aisagbonhi O, Harrison B, Zhao L, Osgood R, Chebib I, Oliva E. YWHAE Rearrangement in a Purely Conventional Low-grade Endometrial Stromal Sarcoma that Transformed Over Time to High-grade Sarcoma: Importance of Molecular Testing. International Journal of Gynecological Pathology 2018;37:441-7. [DOI: 10.1097/pgp.0000000000000451] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
30 Tuyaerts S, Amant F. Endometrial Stromal Sarcomas: A Revision of Their Potential as Targets for Immunotherapy. Vaccines (Basel) 2018;6:E56. [PMID: 30149610 DOI: 10.3390/vaccines6030056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
31 Manuel V, Dinato FJ, Gutierrez PS, Siqueira SAC, Gaiotto FA, Jatene FB. Cardiac metastatic endometrial stromal sarcoma 17 years after hysterectomy. J Card Surg 2017;32:636-8. [DOI: 10.1111/jocs.13221] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
32 Seagle BL, Shilpi A, Buchanan S, Goodman C, Shahabi S. Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study. Gynecol Oncol. 2017;146:254-262. [PMID: 28596015 DOI: 10.1016/j.ygyno.2017.05.036] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 9.3] [Reference Citation Analysis]
33 Yen MS, Chen JR, Wang PH, Wen KC, Chen YJ, Ng HT; Taiwan Association of Gynecology Systematic Review Group. Uterine sarcoma part III-Targeted therapy: The Taiwan Association of Gynecology (TAG) systematic review. Taiwan J Obstet Gynecol 2016;55:625-34. [PMID: 27751406 DOI: 10.1016/j.tjog.2016.07.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]